Reuters
01 Oct 2025, 20:12 UTC · 49w ago
Verdict
Headline takes no side. We score GLPG +0.40 across one claim — moderately bullish.
+0.40moderately bullish
More positive than 66% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
Galapagos has received non-binding offers from consortia of financial investors to acquire its cell-therapy business.
More positive than 91% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 66% of ticker scores this week
The company has received non-binding offers for its cell-therapy business, indicating potential strategic value and capital infusion.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
1d ago
−20.1%
Price is moving against the score
$27.98 vs $35.04 close before publication (Oct 1) · not market-adjusted
GLPG chart →
